Firefly Neuroscience shares surged 45% pre-market after reporting massive operational growth. The company announced a 20-fold increase in its commercial footprint and a 33-fold jump in EEG/ERP brain scan volumes over the past year. With 99 commercial sites and over 10,800 scans completed in 2025, the company highlighted a significant breakout in its commercial activity.